Latest News

HPRA Stakeholder Event UpdateMeeting: 31st A...

Read more

Diamond Pharma Services will be exhibiting at the TOPRA symposium 2nd-4th October&...

Read more

HPRA Stakeholder Brexit Event Update


HPRA Stakeholder Event UpdateMeeting: 31st August 2017Meeting update is provided by Nicholas Littlebury, Deputy Managing Director of Diamond BioPharm Limited. The meeting update i...

Read more

Meet Diamond at the TOPRA Symposium 2017 in London


Diamond Pharma Services will be exhibiting at the TOPRA symposium 2nd-4th October 2017 in London at the Park Plaza Hotel in Victoria. We look forward to meeting you t...

Read more

Development Stage Regulatory Support


Diamond Pharma Services has extensive experience in assisting companies to navigate through clinical development. We provide a wide range of services including: REGULATORY GAP ANALYSIS AND DEVELOPMENT PLANSNATIONAL AND EMA SCIENTIFIC ADVICE MEETINGS

Read more

Delivering on Outsourced Regulatory Services


Sometimes there is sound logic for a pharmaceutical company to outsource a significant part of their regulatory tasks to a stable and experienced team. Diamond Pharma Services has been a trusted resource for a variety of companies looking to: OVERCOME A SIGNIFICANT...

Read more

Overseas MHRA GMP Inspection Success


Diamond Compliance and Quality Limited (DCQ) are pleased to announce the positive outcome of the first on-site GMP regulatory audit, by UK's Medicines and Healthcare products Regulatory Agency (MHRA), of an overseas client in Bangladesh. A DCQ representative undert...

Read more

The Brexit Package


Brexit Considerations for March 2019

Read more

Response to the UK's Withdrawal from the EU


Harlow, UK, 5th May 2017On 2nd May 2017 the EMA and European Commission published a notice alerting Marketing Authorisation Holders of centrally authorised medicines of their obligations in relation to Brexit.1 Although the final d...

Read more

EMA launches new pilot to support development of biosimilars


The European Medicines Agency (EMA) will launch a pilot project in February 2017 to test the added value and feasibility of tailored scientific advice for the development path of biosimilar medicines. Through this new initiative, EMA aims to provide developers of biosimilars w...

Read more

Diamond Pharma Services at Phacilitate 2017


Will you be attending Phacilitate Leader's Forum in Miami on the 18th? Stop by booth 135 and have a chat with Diamond Pharma Services about your regulatory affairs requirements. Diamond Pharma Services will be attending this year's Phacilitate Lead...

Read more

Brexit: Business as usual for Diamond Pharma Services


EU Referendum Result: Business as usual for the Diamond Pharma Services group of companies

Read more

Responsive image